ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries, and protects the environment. Thousands of scientists from industry and academia benefit from gaining access to state-of-the-art infrastructure, facilities and instruments every year.
The OPAL reactor is a state-of-the-art 20 MW multi-purpose reactor with the capacity to produce commercial quantities of radioisotopes for nuclear medicine, representing a sovereign capability for Australia.
The ANSTO NIF Node partners with pharmaceutical, biomedical and medical devices companies to bring new products and methods to market. It draws on capabilities in radiochemistry, physics, biology, and preclinical imaging to develop a greater understanding of disease states, and improve diagnosis and treatment methods.
The Node is focused on emerging opportunities in radioisotope technologies, radiolabelling methods for therapeutic radiopharmaceuticals, and the growing field of theranostics, taking advantage of ready access to radioisotopes produced in the OPAL reactor.
The Node is establishing a new facility to enable the development and translation of alpha-emitting therapeutic radiopharmaceuticals.
New Illawarra Rd
Lucas Heights NSW 2234